Robuta

https://www.news-medical.net/news/20260420/Single-CAR-T-infusion-shows-strong-response-in-patients-with-high-risk-smoldering-multiple-myeloma.aspx Single CAR T infusion shows strong response in smoldering multiple myeloma patients Apr 21, 2026 - A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering... smoldering multiple myelomasingle car https://www.hmpgloballearningnetwork.com/site/onc/videos/advances-patients-high-risk-smoldering-multiple-myeloma Advances for Patients With High-Risk Smoldering Multiple Myeloma Victor Jimenez Zepeda, MD, discusses the evolving management of patients with high-risk smoldering multiple myeloma. Multiple Myeloma Videos for patientshigh riskadvancessmolderingmultiple https://www.aacr.org/about-the-aacr/newsroom/news-releases/bcma-directed-car-t-cell-therapy-may-be-effective-against-high-risk-smoldering-multiple-myeloma/ BCMA-directed CAR T-cell Therapy May Be Effective Against High-risk Smoldering Multiple Myeloma |... Apr 20, 2026 - All patients were negative for minimal residual disease, and no patients experienced progression to active multiple myeloma during the median 15.3 months of... car t cell therapy https://www.siemens-healthineers.com/es/plasma-protein/n-latex-flc-ratio Early therapy in smoldering multiple myeloma: use of FLC ratio with N Latex FLC assays - Siemens... Published clinical research studies the use of FLC ratio with N Latex FLC assays for patients with smoldering multiple myeloma